Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$411.11
-1.60%
Alpha Vantage · 11/6/2026
Adjusted daily closes · 252 observations · as of Nov 6, 2026
1 month
+10.2%
3 months
+11.8%
6 months
+18.3%
1 year
+31.7%
Year to date
+23.3%
52-week range
$297.78 – $421.30
Latest reported period: Sep 30, 2026
Market cap
$15.23B
P/E
8.1
P/B
1.1
P/S
0.9
Revenue
$16.17B
Net income
$1.89B
Diluted EPS
47.29
Gross margin
21.30%
Net margin
11.70%
Return on equity
12.50%
Total debt
$3.59B
Cash
$987M
Free cash flow
$1.54B
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 30, 2026 | $3.71B | $233M | 14.40% | 6.30% | $667M |
| Jun 30, 2026 | $3.96B | $559M | 24.70% | 14.10% | $290M |
| Mar 31, 2026 | $4.07B | $653M | 25.20% | 16.10% | $649M |
| Dec 31, 2025 | $4.42B | $446M | 20.40% | 10.10% | -$67M |
| Sep 30, 2025 | $4.32B | $255M | 13.70% | 5.90% | $1.46B |
| Jun 30, 2025 | $4.49B | $680M | 25.40% | 15.10% | $1.08B |
| Mar 31, 2025 | $4.26B | $210M | 12.80% | 4.90% | $928M |
| Dec 31, 2024 | $4.64B | -$593M | -9.50% | -12.80% | $780M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Egypt's Industrial Development Bank (IDB) made a net profit of EGP 1bn in 2025, the first time it has reached that mark, and will reward shareholders with bonus shares for the first time in two decades. The lender's ordinary general assembly approved the accounts for the year to 31 December. Management attributed
Original sourceRegency Centers reported strong Q3 2026 results, raising its 2026 same-property NOI growth guidance to 4.25% or higher and increasing its dividend by 6%, driven by record 97% occupancy and robust rent spreads. However, the company's early 2027 outlook projects a deceleration to mid-3% NOI growth, influenced by moderating occupancy gains, normalized bad debt, and high expense recovery rates. Additionally, refinancing maturing debt is expected to reduce long-term earnings growth by 150-200 basis points, leading analysts to press management on future growth drivers and capital allocation.
Original sourceRegeneron Pharmaceuticals reported strong third-quarter 2026 results with US$5.1 billion in revenue and US$1.95 billion in net income, exceeding expectations. The company also affirmed its quarterly dividend and continued share buybacks, while expanding its BARDA agreement for Ebola treatment and presenting positive data for Libtayo in skin cancer. These results reinforce Regeneron's earnings engine, with a focus on late-stage pipeline execution and competition in eye care, and analysts anticipate continued revenue and earnings growth through 2029.
Original sourceGlobal reinsurance company Everest Group (NYSE:EG) reported Q3 2026 revenue of $3.71 billion, falling 14% year-on-year and missing market expectations. The company also missed analysts' consensus estimates for non-GAAP profit per share, net premiums earned, combined ratio, adjusted EPS, and book value per share. Despite the softer quarter, shares edged higher by 1.6% immediately after the report.
Original sourceAnticipation is growing for Edison International's (EIX) Q3 2026 earnings release, with a current share price of US$57.35 following a recent rebound. Analysts view the stock as 10.3% undervalued, largely due to a planned US$38b to US$41b capital program for grid upgrades. However, this optimistic outlook is tempered by ongoing wildfire liability and California policy decisions, creating mixed messages on the company's valuation.
Original source